B4SA weekly update

Dear B4SA and business colleagues,

The Phase 2 vaccination rollout is gathering momentum. Recent figures show that as of 3 June, 1,193,352 adults had received their first jab. This includes those in the Sisonke trial. The number of vaccines administered daily is climbing, and we are now looking at roughly 75,000 per day. There are 2.3 million over 60s who have registered for their vaccinations.

However, we are still in a vaccine constrained environment. Pfizer is supplying 636,000 vaccines per week, and we still await the release of the J&J doses, which US regulatory bodies are checking following possible contamination at the Baltimore facility. Once released, it will add another two million doses to the programme.

The good news is many new vaccination sites have come online in the private and public sectors. One workplace site has come online and has started vaccinating. There are 88 other workplace sites in the pipeline, which will be able to administer a total of 24,300 doses a day. The NDOH selects the sites, and we understand this is based on factors such as vaccine supply, vaccine type, infrastructure requirements, available vaccinators and geographic location, etc. More sites will be brought online as we receive larger volumes of vaccines.

Read more: B4SA weekly update 04 June 21

Scroll to top